Search Results - "SIMUNEK, Tomáš"
-
1
Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection
Published in Antioxidants & redox signaling (10-03-2013)“…Anthracyclines (doxorubicin, daunorubicin, or epirubicin) rank among the most effective anticancer drugs, but their clinical usefulness is hampered by the risk…”
Get more information
Journal Article -
2
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
Published in Pharmacological reports (01-01-2009)“…The risk of cardiotoxicity is the most serious drawback to the clinical usefulness of anthracycline antineoplastic antibiotics, which include doxorubicin…”
Get full text
Journal Article -
3
Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships
Published in PloS one (16-10-2014)“…Thiosemicarbazones (TSCs) are an interesting class of ligands that show a diverse range of biological activity, including anti-fungal, anti-viral and…”
Get full text
Journal Article -
4
Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells
Published in Protein science (01-12-2023)“…Ferritin, a naturally occurring iron storage protein, has gained significant attention as a drug delivery platform due to its inherent biocompatibility and…”
Get full text
Journal Article -
5
2,6-Dihydroxybenzaldehyde Analogues of the Iron Chelator Salicylaldehyde Isonicotinoyl Hydrazone: Increased Hydrolytic Stability and Cytoprotective Activity against Oxidative Stress
Published in Chemical research in toxicology (19-11-2018)“…Salicylaldehyde isonicotinoyl hydrazone (SIH) is a small molecule and lipophilic chelating agent that firmly binds ferric ions from the cellular labile iron…”
Get full text
Journal Article -
6
Structure–Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions
Published in Journal of medicinal chemistry (08-04-2021)“…Cardioprotective activity of dexrazoxane (ICRF-187), the only clinically approved drug against anthracycline-induced cardiotoxicity, has traditionally been…”
Get full text
Journal Article -
7
Water-soluble non-aggregating zinc phthalocyanine and in vitro studies for photodynamic therapy
Published in Chemical communications (Cambridge, England) (01-01-2013)“…Newly synthesized zinc phthalocyanine bearing sixteen quaternized imidazolyl moieties on the periphery displays high water-solubility, lack of aggregation and…”
Get more information
Journal Article -
8
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
Published in Scientific reports (13-06-2022)“…Labile redox-active iron ions have been implicated in various neurodegenerative disorders, including the Parkinson's disease (PD). Iron chelation has been…”
Get full text
Journal Article -
9
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity
Published in Scientific reports (24-02-2021)“…The bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 has been previously identified as a more potent analog of dexrazoxane (ICRF-187), a drug used in…”
Get full text
Journal Article -
10
Flavonoids as protectors against doxorubicin cardiotoxicity: Role of iron chelation, antioxidant activity and inhibition of carbonyl reductase
Published in Biochimica et biophysica acta (01-09-2007)“…Anthracycline antibiotics (e.g. doxorubicin and daunorubicin) are among the most effective and widely used anticancer drugs. Unfortunately, their clinical use…”
Get full text
Journal Article -
11
Far-Red-Absorbing Cationic Phthalocyanine Photosensitizers: Synthesis and Evaluation of the Photodynamic Anticancer Activity and the Mode of Cell Death Induction
Published in Journal of medicinal chemistry (26-02-2015)“…Novel zinc, magnesium, and metal-free octasubstituted phthalocyanine photosensitizers bearing [(triethylammonio)ethyl]sulfanyl substituents in the peripheral…”
Get full text
Journal Article -
12
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation
Published in Circulation. Heart failure (01-11-2021)“…Anthracycline-induced heart failure has been traditionally attributed to direct iron-catalyzed oxidative damage. Dexrazoxane (DEX)-the only drug approved for…”
Get full text
Journal Article -
13
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage
Published in Toxicological sciences (01-04-2024)“…Anthracyclines, such as doxorubicin (adriamycin), daunorubicin, or epirubicin, rank among the most effective agents in classical anticancer chemotherapy…”
Get full text
Journal Article -
14
Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury
Published in Free radical biology & medicine (01-09-2014)“…Oxidative stress is a common denominator of numerous cardiovascular disorders. Free cellular iron catalyzes the formation of highly toxic hydroxyl radicals,…”
Get full text
Journal Article -
15
Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up
Published in PloS one (07-05-2014)“…Chronic anthracycline cardiotoxicity is a serious clinical issue with well characterized functional and histopathological hallmarks. However, molecular…”
Get full text
Journal Article -
16
Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury
Published in Toxicology (Amsterdam) (14-09-2016)“…Highlights • Fe prochelator BHAPI was examined for protection against catecholamine cardiotoxity. • BHAPI has no affinity for iron ions until it is activated…”
Get full text
Journal Article -
17
Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity
Published in Free radical biology & medicine (15-02-2011)“…Elevated catecholamine levels are known to induce damage of the cardiac tissue. This catecholamine cardiotoxicity may stem from their ability to undergo…”
Get full text
Journal Article -
18
Tetra(3,4-pyrido)porphyrazines Caught in the Cationic Cage: Toward Nanomolar Active Photosensitizers
Published in Journal of medicinal chemistry (27-10-2016)“…Investigation of a series of tetra(3,4-pyrido)porphyrazines (TPyPzs) substituted with hydrophilic substituents revealed important structure–activity…”
Get full text
Journal Article -
19
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications
Published in European journal of medicinal chemistry (14-09-2016)“…Aroylhydrazones such as salicylaldehyde isonicotinoyl hydrazone (SIH) are tridentate iron chelators that may possess antioxidant and/or antineoplastic…”
Get full text
Journal Article -
20
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells
Published in PloS one (07-10-2013)“…Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is hampered by the risk of…”
Get full text
Journal Article